RheumConnect - Music City Rheumatology Summit

Nashville, TN US


Thank you for joining us at the ARTHROS Music City Rheumatology Review in Nashville, Tennessee! 

The RheumConnect regional series will employ a multi-faceted approach for delivering content using didactic and performance-based active learning. The focus will be on new concepts regarding disease etiology, clinical presentation, phenotype, and emerging therapies.

Please select “Register/Take Course” to complete the following:

  • Pre-test

  • Post-test

  • Program evaluation

Upon completion, you will receive your accreditation certificate. 

The pre-test will close on Saturday, September 24 at 11:00 AM CDT.

The post-program activities will become available on Saturday, September 24 at 3:00 PM CDT.

Target Audience

This initiative is designed for rheumatology clinicians and health care professionals who treat rheumatic disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review data on the prevalence of rheumatic diseases
  • Describe the progressive nature and detrimental effects of untreated rheumatic diseases
  • Discuss updates in diagnosis, classification and treatment guidelines and demonstrate strategies to incorporate these guidelines into practice
  • Analyze recently approved and emerging treatment options, including a review of their safety and efficacy through analysis of how new agents are improving patient care
  • Identify and analyze any "hot topics" in specific areas of rheumatic disease (such as the use of biosimilars, new treatments for psoriatic disease, vasculitis, gout, and drugs in development)
Course summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit
  • 5.00 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
Course expires: 
Renaissance Nashville Hotel
611 Commerce Street
Nashville, TN 37203
United States

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

Purdue University College of Pharmacy designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure/Conflict of Interest Policy

To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

All relevant conflicts of interest have been mitigated prior to the start of the activity.

None of the planners, reviewers, Focus Medical Communications staff, and Purdue University College of Pharmacy staff have relevant financial relationship(s) with ineligible companies to disclose unless listed below.

Supported by an educational grant from Janssen Biotech.

Available Credit

  • 5.00 AMA PRA Category 1 Credit
  • 5.00 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.